HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhanyang Yu Selected Research

Neuroglobin

1/2018Amyloid-β25-35 Upregulates Endogenous Neuroprotectant Neuroglobin via NFκB Activation in vitro.
1/2018Neuroglobin promotes neurogenesis through Wnt signaling pathway.
1/2016Establishment of Cell-Based Neuroglobin Promoter Reporter Assay for Neuroprotective Compounds Screening.
8/2013Neuroglobin overexpression inhibits oxygen-glucose deprivation-induced mitochondrial permeability transition pore opening in primary cultured mouse cortical neurons.
2/2013Transcriptional regulation of mouse neuroglobin gene by cyclic AMP responsive element binding protein (CREB) in N2a cells.
1/2013Mitochondrial mechanisms of neuroglobin's neuroprotection.
6/2012Neuroglobin-overexpression reduces traumatic brain lesion size in mice.
4/2012Transcriptional regulation mechanisms of hypoxia-induced neuroglobin gene expression.
1/2012Neuroglobin, a novel target for endogenous neuroprotection against stroke and neurodegenerative disorders.
12/2011Neuroglobin is an endogenous neuroprotectant for retinal ganglion cells against glaucomatous damage.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhanyang Yu Research Topics

Disease

14Stroke (Strokes)
01/2020 - 06/2010
10Ischemia
05/2024 - 03/2009
7Hypoxia (Hypoxemia)
01/2021 - 01/2009
6Traumatic Brain Injuries (Traumatic Brain Injury)
01/2021 - 06/2012
6Hyperglycemia
01/2020 - 02/2012
5Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2012
4Ischemic Stroke
01/2023 - 06/2010
4Brain Infarction
12/2018 - 06/2010
4Embolic Stroke
12/2017 - 06/2010
3Brain Ischemia (Cerebral Ischemia)
05/2024 - 11/2019
3Type 2 Diabetes Mellitus (MODY)
01/2020 - 12/2018
3Neuroinflammatory Diseases
12/2019 - 06/2018
3Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
12/2018 - 06/2010
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2018 - 01/2012
3Brain Injuries (Brain Injury)
03/2016 - 06/2012
2Edema (Dropsy)
05/2024 - 06/2010
2Inflammation (Inflammations)
01/2022 - 06/2018
2Brain Edema (Cerebral Edema)
01/2021 - 03/2016
2Neuroblastoma
03/2019 - 01/2018
2Nervous System Diseases (Neurological Disorders)
01/2018 - 01/2013
2Infarction (Infarctions)
08/2015 - 02/2014
2Hemorrhage
08/2015 - 10/2010
1Neoplasms (Cancer)
01/2023
1Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
01/2022
1Amyloidosis
01/2020
1Hyperlipidemias (Hyperlipidemia)
06/2018
1Insulin Resistance
06/2018
1Obesity
06/2018
1Cognitive Dysfunction
06/2018
1Mitochondrial Diseases (Mitochondrial Disease)
04/2015
1Brain Diseases (Brain Disorder)
01/2012
1Ocular Hypertension (Glaucoma, Suspect)
12/2011
1Thrombosis (Thrombus)
06/2010

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
05/2024 - 06/2010
12NeuroglobinIBA
01/2018 - 01/2009
10Annexin A2 (Annexin II)IBA
01/2023 - 06/2010
8Tissue Plasminogen Activator (Alteplase)FDA Link
12/2017 - 06/2010
4Glucose (Dextrose)FDA LinkGeneric
01/2021 - 04/2015
4fibroblast growth factor 21IBA
01/2020 - 06/2018
3Oxygen (Dioxygen)IBA
01/2021 - 01/2013
3Messenger RNA (mRNA)IBA
01/2020 - 12/2018
3CytokinesIBA
01/2020 - 03/2016
3Neuroprotective AgentsIBA
12/2018 - 12/2011
2Amyloid (Amyloid Fibrils)IBA
01/2022 - 01/2020
2polysialyl neural cell adhesion moleculeIBA
03/2019 - 01/2018
2GlobinsIBA
01/2013 - 12/2011
1Small Interfering RNA (siRNA)IBA
05/2024
1Dextrans (Dextran)FDA Link
05/2024
1Neurotransmitter Receptors (Neurotransmitter Receptor)IBA
01/2022
1EphB2 ReceptorIBA
01/2021
1Ephrin-B2 (Ephrin B2)IBA
01/2021
1Annexin A1IBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1InterleukinsIBA
01/2020
1Trace Elements (Biometals)IBA
01/2020
15' Untranslated Regions (5' UTR)IBA
01/2020
1Vascular Endothelial Growth Factor CIBA
11/2019
1Interleukin-1beta (Interleukin 1 beta)IBA
05/2019
1histone deacetylase 3IBA
05/2019
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
12/2018
1rat endothelial barrier antigenIBA
12/2017
1Immunoglobulin G (IgG)IBA
12/2017
1FibrinIBA
12/2017
1CollagenIBA
12/2017
1cadherin 5IBA
12/2017
1Matrix Metalloproteinases (MMPs)IBA
12/2017
1Thrombospondin 1IBA
01/2017
1Complement System Proteins (Complement)IBA
03/2016
1ApolipoproteinsIBA
03/2016
1ClusterinIBA
03/2016
1Evans Blue (Blue, Evans)FDA Link
03/2016
1Amyloid beta-PeptidesIBA
01/2016
1IronIBA
08/2015
1Therapeutic UsesIBA
08/2015
1SynaptophysinIBA
02/2014
1Biomarkers (Surrogate Marker)IBA
02/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2014
1ElementsIBA
04/2012
1Superoxides (Superoxide)IBA
12/2011
1Adenosine Triphosphate (ATP)IBA
12/2011
1Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA
06/2010
1Apoptosis Inducing FactorIBA
06/2010
1FibrinolysinFDA Link
06/2010

Therapy/Procedure

12Therapeutics
12/2018 - 06/2010
2Thrombolytic Therapy
01/2014 - 06/2010
1Treatment Delay
08/2015